We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Richard Lafferty has been assisting clients through the H1B Visa process since 2021.

As of 2022, Richard Lafferty has succesfully submitted and recieved certification for 193 cases.

Richard Lafferty is located in New York, NY, and has represented 5 employers for the H1B Visa Process

194
Cases Handled
193
Cases Certified
99.48%
Approval

Cases Handled by Richard Lafferty

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-24107-889979 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24103-880292 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24087-832866 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24085-826116 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24081-818413 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24080-814775 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24078-806980 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24078-806847 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24075-802393 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024
I-200-24074-798305 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2024